Skip to main content

Now live! Explore the program for the upcoming 2024 Global Conference, taking place May 5-8, 2024.

Kirk Kaminsky

< Back to previous page

Kirk Kaminsky

President, McKesson, Pharmaceutical Solutions and Services
Kirk Kaminsky

Kirk Kaminsky is President of U.S. Pharmaceutical for McKesson Corporation. Kirk is responsible for providing leadership and strategic direction for McKesson’s best-in-class wholesale drug distribution and value-added technology solutions for retail pharmacies, health systems, payers and community providers in the U.S. Kirk also leads the development of the company’s oncology ecosystem, a strategic growth pillar, through The US Oncology Network, Sarah Cannon Research Institute, Ontada and Biologics by McKesson specialty pharmacy. Kirk joined McKesson in 2003 and has served in a variety of leadership roles at the company. Most recently, Kirk headed the Specialty Provider Organization, a division of U.S. Pharmaceutical and served as President of The US Oncology Network, led the U.S. Pharmaceutical packaging business and was a member of the company’s Corporate Strategy and Business Development function. Prior to joining McKesson, Kirk worked in investment banking as a financial analyst, concentrating on corporate finance for healthcare and consumer retail. Kirk holds a Bachelor of Arts in Economics for Business from Occidental College a Master of Business Administration from The Wharton School.